Facebook Tracking Image

National Comprehensive Cancer Network

NCCN Global

Supporters of the NCCN Global Program

National Comprehensive Cancer Network® (NCCN®) gratefully acknowledges the support and commitment of the following companies to the improvement of the treatments available to the patients whom we all serve. We also appreciate the recognition of NCCN's necessary autonomy in all decision-making regarding the conclusions, recommendations and outcomes of NCCN programs and resources.

Global Corporate Council

The NCCN Global Corporate Council is an important resource for the development and expansion of NCCN programs and resources.

NCCN offers membership into the NCCN Global Corporate Council to significantly enhance collaborative efforts between pharmaceutical and biotechnical companies and NCCN, and thus better serve patients. NCCN gratefully acknowledges the support and commitment of the following companies through NCCN Global Corporate Council:

Abbvie Company Logo Amgen Company Logo Astellas Company Logo AstraZeneca  Company Logo
Bayer Company Logo BeiGene Company Logo Daiichi-Sankyo Company Logo Genomic Health Company Logo
Helsinn Company Logo Incyte Company Logo Ipsen Company Logo Janssen Company Logo
Lilly Oncology Company Logo Merck KGaA Company Logo Myriad Company Logo Novartis Company Logo
Regeneron Company Logo Roche Company Logo Sanofi Company Logo Seattle Genetics Company Logo
Servier Company Logo Takeda Oncology Company Logo Tesaro Company Logo

NCCN is grateful for the support of our US NCCN Corporate Council Members. To view a full list of NCCN Corporate Council Members, click here.

General Mission Support

NCCN is seeking general mission support for its mission-related international work. General Mission Support can be specified by region, program, and/or disease type.

Janssen supported NCCN’s mission work in Sub-Saharan Africa. General Mission Support has empowered NCCN to proactively develop global programs that have huge impact in resource constrained populations in Africa.  

Merck KGaA, Darmstadt, Germany supported NCCN’s Mission work related to global patient advocacy engagement.

Takeda Oncology supported NCCN’s global general mission specific to translation of NCCN Content. NCCN was able to continue the translation, verification, and subsequent maintenance/updates of several NCCN Guidelines into multiple languages, including Spanish, Portuguese, Chinese, South Korean, French, German, and Italian.

Get Involved - Opportunities for Collaboration and Sponsorship are available!